Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin-associated protein 28-6 (KRTAP28-6, also referred to as small cysteine and glycine repeat-containing protein 6, SCYGR6) is a member of the keratin-associated protein family. KAPs are structural proteins that cross-link with keratin intermediate filaments via disulfide bonds, helping to form the structure and mechanical properties of hair and wool fibers. The KAP family is large and diverse, with numerous members involved in the matrix of hair and wool; these proteins exhibit considerable sequence variation and polymorphism. There is no direct evidence for KRTAP28-6 as a therapeutic or pharmacological target, nor is there significant association with human diseases beyond its structural role in hair and wool[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin-associated protein 28-6 (KRTAP28-6).